...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor.
【24h】

Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor.

机译:使用来自粒细胞集落刺激因子治疗的供体的外周血祖细胞改进的祖细胞测定标准化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Progenitor assays are the principal method for evaluating hematopoietic cell function. The magnitude of assay variability and the assay steps contributing to variability were determined, and modifications intended to increase assay consistency were evaluated. STUDY DESIGN AND METHODS: Assays were performed using a serum-free progenitor assay medium with cells plated at 5.0 x 10(4) and 1.0 x 10(5) cells per plate. A peripheral blood progenitor cell component collected from a normal donor after administration of granulocyte-colony-stimulating factor was divided into identical aliquots. Each experiment involved at least 5 technologists, each performing assays in duplicate on five aliquots, with each person scoring all assay plates. Three sample preparation methods were tested: 1) ficoll mononuclear cell enrichment and sample dilution, 2) sample dilution without ficoll separation, and 3) sample dilution without ficoll separation, with cell counts performed before and after each dilution step, dilution volumes calculated on the basis of each cell count, automated electronic pipettors used in dilution steps, and colony frequency calculated on the basis of cell counts from the final specimen. RESULTS: Global variability for colony-forming units-granulocyte-macrophage, represented by the percentage of CV for all specimens and all technologists, was 89.6 percent at 5.0 x 10(4) cells per plate and 81.3 percent at 1.0 x 10(5), when ficoll separation was used. Subjective differences in scoring plates did not account for most of the variability observed, as results for any individual plate read by multiple technologists had a mean CV of 15.6 percent and 19.7 percent at the two plating concentrations. Method 3 resulted in the greatest improvement, reducing CV to 24.4 percent at 5.0 x 10(4) cells per plate and to 24.2 percent at 1.0 x 10(5) cells per plate. Similar results were obtained for erythroid-burst-forming units. CONCLUSIONS: Baseline assay results were extremely inconsistent. Interindividual differences in colony interpretation did not contribute significantly to assay variability, although sample preparation and plating did. Improved control over cell concentration decreased assay variability by 70 to 73 percent.
机译:背景:祖细胞测定是评估造血细胞功能的主要方法。确定了测定变异性的大小和有助于变异性的测定步骤,并评估了旨在增加测定一致性的修饰方法。研究设计和方法:使用无血清祖细胞分析培养基进行实验,每平板接种细胞为5.0 x 10(4)和1.0 x 10(5)细胞。给予粒细胞集落刺激因子后,从正常供体收集的外周血祖细胞成分分成相同的等分试样。每个实验至少涉及5位技术人员,每位技术人员一式五份地进行一式两份的测定,每个人对所有测定板进行评分。测试了三种样品制备方法:1)ficoll单核细胞富集和样品稀释; 2)不进行ficoll分离的样品稀释; 3)不进行ficoll分离的样品稀释;在每个稀释步骤之前和之后进行细胞计数,根据每个细胞计数的基础,用于稀释步骤的自动电子移液器以及根据最终样本中细胞计数计算的菌落频率。结果:集落形成单位-粒细胞-巨噬细胞的总体变异性(以所有标本和所有技术人员的CV百分比表示)在每块平板5.0 x 10(4)个细胞中为89.6%,在1.0 x 10(5)个条件下为81.3%。 ,当使用ficoll分离时。得分板的主观差异并不能解释观察到的大部分变异性,因为由多个技术人员读取的任何单个板的结果在两个板浓度下的平均CV分别为15.6%和19.7%。方法3带来了最大的改进,在每块板5.0 x 10(4)个单元中,CV降低到24.4%,在每块板1.0 x 10(5)个单元中,CV降低到24.2%。红系爆裂形成单位获得了相似的结果。结论:基线测定结果极为不一致。尽管样本制备和接种确实有一定差异,但菌落解释的个体差异并没有显着影响测定的可变性。更好地控制细胞浓度可将测定变异性降低70%至73%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号